Diagnostic Criteria for Acute Kidney Injury
Acute kidney injury is diagnosed using the KDIGO criteria: an increase in serum creatinine ≥0.3 mg/dL within 48 hours, OR an increase to ≥1.5 times baseline within 7 days, OR urine output <0.5 mL/kg/h for 6 consecutive hours. 1
Core Diagnostic Criteria
The KDIGO classification system provides the current standard for AKI diagnosis and staging, combining both creatinine and urine output parameters 1, 2:
Serum Creatinine Criteria
- Any increase of ≥0.3 mg/dL (26.5 μmol/L) within 48 hours 1
- OR increase to ≥1.5 times baseline (presumed to have occurred within prior 7 days) 1
Urine Output Criteria
- Urine volume <0.5 mL/kg/h for 6 consecutive hours 1
Critical point: You need to meet only ONE criterion (either creatinine OR urine output) to diagnose AKI. 1
Staging System
Once AKI is diagnosed, severity is classified into three stages based on the worst criterion met 1:
Stage 1
- Creatinine increase 1.5-1.9 times baseline OR increase ≥0.3 mg/dL 1
- Urine output <0.5 mL/kg/h for 6-12 hours 1
Stage 2
Stage 3
- Creatinine increase ≥3.0 times baseline OR increase to ≥4.0 mg/dL (with acute rise of ≥0.3 mg/dL) OR initiation of renal replacement therapy 1
- Urine output <0.3 mL/kg/h for ≥24 hours OR anuria for ≥12 hours 1
The progression through stages strongly correlates with mortality—even small creatinine increases of 0.3 mg/dL independently increase hospital mortality approximately four-fold. 1
Special Populations: Cirrhosis with Ascites
In patients with cirrhosis and ascites, focus exclusively on serum creatinine changes and disregard urine output criteria. 1 This population presents unique diagnostic challenges:
- These patients are frequently oliguric with avid sodium retention despite maintaining relatively normal GFR 3, 1
- Diuretic therapy further confounds urine output interpretation 3, 1
- A creatinine threshold of ≥1.5 mg/dL predicts AKI progression and worse prognosis in cirrhotic patients 3, 1
For cirrhotic patients with Stage 1 AKI, those whose peak creatinine exceeds 1.5 mg/dL (stage 1-B) have significantly higher short-term mortality compared to those remaining below 1.5 mg/dL (stage 1-A) 3
Critical Diagnostic Pitfalls
Limitations of Serum Creatinine
Serum creatinine significantly overestimates actual kidney function in several populations 1:
- Patients with muscle wasting (decreased creatinine production from muscles) 1
- Increased tubular secretion of creatinine 1
- Volume expansion diluting creatinine concentration 1
- Hyperbilirubinemia interfering with colorimetric assays 1
Do not wait for creatinine to reach 1.5 mg/dL before diagnosing AKI—this outdated threshold indicates GFR has already fallen to approximately 30 mL/min. 1 Instead, monitor temporal changes at 48-hour intervals to detect the 0.3 mg/dL threshold 1
Limitations of Urine Output
Beyond cirrhotic patients, urine output criteria are unreliable in 1, 4:
- Patients receiving diuretics (artificially increases urine output) 4
- Patients with pre-existing oliguria from other causes 1
The Fractional Excretion of Sodium (FENa) becomes unreliable after diuretic administration and should not be used in these patients. 4
Practical Diagnostic Approach
Initial Evaluation
- Obtain baseline creatinine (if unknown, assume occurred within prior 7 days) 1
- Measure current creatinine and calculate change 1
- Assess urine output over 6-hour periods (unless patient has cirrhosis/ascites or is on diuretics) 1
- Perform urinalysis with microscopy to help differentiate etiology 1:
Monitoring Strategy
- Serial creatinine measurements every 48 hours for detecting the 0.3 mg/dL threshold 1, 4
- Continuous urine output monitoring in 6-hour blocks (matches nursing shifts and is equivalent to hourly monitoring) 1
- Renal ultrasound to evaluate kidney size and rule out obstruction 1
When to Diagnose
Diagnose AKI immediately when any single criterion is met—do not wait for multiple criteria or higher thresholds. 1 Early detection based on initial marker changes is critical, as even Stage 1 AKI significantly increases mortality risk 1